• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 醣聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

醣聯

(4168)
可現股當沖
  • 股價
    23.80
  • 漲跌
    ▼0.05
  • 漲幅
    -0.21%
  • 成交量
    109張
  • 產業
    上櫃 生技醫療類股▲0.61%

  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
醣聯 (4168)籌碼相關－大昌-樹林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

大昌-樹林 券商分點個股進出

大昌-樹林 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/06124.7000.0024.6011620.61%
2024/12/3000.00125.4025.30-1168-0.59%
2024/12/2700.00125.7025.50-1167-0.60%
2024/12/19326.1000.0026.0031621.85%
2024/12/18225.75125.5525.6511570.63%
2024/12/0600.00124.6024.60-1151-0.66%
2024/11/2000.00124.8524.80-1173-0.58%
2024/11/14125.35125.4024.7001940.00%
2024/11/08125.3500.0025.3011940.51%
2024/11/07125.5000.0025.5011960.51%
2024/11/0500.00225.4525.50-2202-0.99%
2024/10/2800.00026.2026.200234-0.01%
2024/10/25226.4000.0026.6522350.86%
2024/10/2400.00025.6025.8002430.00%
2024/10/22026.0000.0025.8002530.00%
2024/09/2600.00425.3025.30-4472-0.85%
2024/09/2500.00025.3725.4504860.00%
2024/09/2400.00225.4525.40-2511-0.39%
2024/09/20026.0000.0025.7506140.00%
2024/09/1900.00025.7525.7506720.00%
2024/09/18125.8200.0025.7517120.14%
2024/09/16225.7000.0025.6527200.28%
2024/09/1000.00225.9025.85-2733-0.27%
2024/08/2300.00127.5027.40-1906-0.11%
2024/08/2000.00027.1527.3509000.00%
2024/08/19327.0000.0027.1038950.34%
2024/08/1500.00225.8525.85-2881-0.23%
2024/08/06124.8000.0024.8018710.11%
2024/08/05125.4000.0025.1518590.12%
2024/08/02127.4000.0027.2018490.12%
2024/07/31127.5000.0027.6018400.12%
2024/07/2900.00227.6827.55-2834-0.24%
2024/07/1900.00430.2429.60-4798-0.50%
2024/07/18130.7000.0030.5017830.13%
2024/07/16130.60430.1830.10-3748-0.40%
2024/07/15630.98231.2030.5047440.54%
2024/07/1000.00130.7530.40-1713-0.14%
2024/07/09230.2800.0030.3527130.28%
2024/07/0800.00231.3031.05-2708-0.29%
2024/07/05230.78430.9531.00-2692-0.29%
2024/07/0300.00029.3529.6507200.00%
2024/07/02129.90029.9029.4517140.14%
2024/07/01630.501130.4230.40-5696-0.72%
2024/06/281130.75230.4230.1096791.32%
2024/06/27230.70330.7830.00-1656-0.15%
2024/06/26430.271028.6830.65-6600-1.00%
2024/06/25329.22329.6429.0005530.00%
2024/06/24328.211228.0528.75-9496-1.80%
2024/06/21227.2800.0026.9524590.44%
2024/06/2000.00227.2026.55-2452-0.44%
2024/06/19126.40126.5526.4004450.00%
2024/06/181026.9500.0027.00104452.24%
2024/06/14126.55026.4526.5514450.22%
2024/06/13226.62126.8526.5514430.23%
2024/06/11227.6000.0027.5524360.46%
2024/06/07027.7500.0027.1504300.00%
2024/06/0600.00027.4526.9504300.00%
2024/06/05028.45028.0527.6504240.00%
2024/06/04127.3000.0027.5014300.23%
2024/06/03828.23428.0027.7544430.90%
2024/05/31028.15128.1528.20-1374-0.26%
2024/05/30026.3000.0025.6503270.00%
2024/05/2900.00025.3026.2503310.00%
2024/05/2800.00125.5525.55-1324-0.31%
2024/05/27025.7000.0025.6003250.00%
2024/05/2200.00125.4025.40-1323-0.31%
2024/05/1500.00325.3025.15-3323-0.93%
2024/05/14025.6500.0025.3003250.00%
2024/05/1300.00024.7524.950327-0.01%
2024/05/10025.1000.0025.0003270.01%
2024/05/0900.00024.9624.950328-0.01%
2024/05/08025.5000.0024.9003290.01%
2024/05/0200.00125.3025.30-1330-0.30%
2024/04/25225.4000.0025.4023240.62%
2024/04/24125.4000.0025.6013240.31%
2024/04/19225.4500.0025.4023270.61%
2024/04/1700.00126.0026.00-1323-0.31%
2024/04/16126.00225.5525.50-1323-0.31%
2024/04/15126.1500.0026.0513190.31%
2024/04/121426.8700.0026.85143134.46%
2024/04/11127.50027.0027.4013060.32%
2024/04/10728.15028.1528.0572932.38%
2024/04/09026.4500.0027.2502510.01%
2024/04/08025.2000.0025.3502320.00%
2024/04/0100.00124.9525.10-1244-0.41%
2024/03/22025.0000.0024.9502580.00%
2024/03/2000.00524.6624.75-5255-1.96%
2024/03/08225.7000.0025.4522640.76%
2024/03/07325.0000.0024.6532501.20%
2024/03/06126.1500.0026.0012320.43%
2024/02/26127.1000.0027.2512240.45%
2024/02/02127.1000.0027.0512360.42%
醣聯生物相似藥正式進入臨床三期 2026年Q2解盲Anue鉅亨－2024/12/17
...詳全文
醣聯完成生物相似藥一期試驗 Q4啟動三期臨床Anue鉅亨－2024/08/19
...詳全文
醣聯完成生物相似藥SPD8一期試驗 將啟動三期臨床UDN聯合新聞網－2024/08/18
醣聯（4168）16日宣布，與日本三菱瓦斯化學株式會社（MGC）合作開發的Denosumab生物相似藥SPD8，已於日本......詳全文
醣聯 相關文章
醣聯 相關影音